Biostock publishes an article about Prolight finalises instrument design and prepare for pilot manufacturing

Nyheter Prolight Diagnostics Nyheter alla bolag

Courtagefri handel på Nordnet till sista juni 2027! Har du inget konto på Nordnet så är det verkligen läge att skaffa ett. Just nu får nya kunder courtagefri handel till sista juni 2027. Läs mer om erbjudandet och skapa ditt konto här

Erbjudandet gäller nya kunder och omfattar handel via Nordnets app eller hemsida i nordiska aktier, ETF:er, teckningsrätter och teckningsoptioner. För fullständiga villkor se nordnet.se/jubileum. Kom ihåg att investeringar alltid innebär en risk.

Biostock publishes an article about Prolight finalises instrument design and prepare for pilot manufacturing

Biostock publishes an article about Prolight finalises instrument design and prepare for pilot manufacturing. This marks a pivotal step towards the production of pilot units intended for the upcoming clinical performance study. BioStock reached out to Paul Monaghan, Head of Engineering, to learn more.

Read the full article here: https://biostock.se/en/2026/01/prolight-slutfor-instrumentdesign-och-forbereder-for-pilottillverkning/

About Us
Prolight Diagnostics AB develops innovative Point-of-Care systems. These are small, portable instruments and disposable cartridges for performing in-vitro diagnostic (IVD) tests from a drop of blood. We want to offer the foremost POC systems on the market for quick, reliable diagnosis of acute events. Our launch product will be for the measurement of high sensitive troponin, to aid in the rule-in and rule-out of myocardial infarction.

The company’s share is traded on the NGM Nordic SME marketplace, under the ticker PRLD.

Datum	2026-01-30, kl 08:00
Källa	MFN

Bifogade filer

Biostock publishes an article about Prolight finalises instrument design and prepare for pilot manufacturing

LOGGA IN

Prolight Diagnostics

Affiliate

Biostock publishes an article about Prolight finalises instrument design and prepare for pilot manufacturing